Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,734 across all filing types
Latest filing 2021-05-13 Director's Dealing
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
110年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, chairman, general manager, and other executives. It includes specific data on shares held, increases, decreases, and trust shares. The content is focused on insider shareholding disclosures rather than financial results, management changes, or meeting materials. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2021-05-13 Chinese
110年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, pledged shares, and related information. It is focused on reporting insider shareholdings and changes thereof. There is no indication of financial statements, earnings data, or meeting materials. The document is not a report publication announcement or a certification. The content aligns with disclosures about insider shareholdings or director dealings. Given the detailed insider shareholding data, the document best fits the category of Director's Dealing (DIRS). The document length is 3455 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full annual report.
2021-05-13 Chinese
公告本公司遭公平交易委員會處以罰鍰事宜
Legal Proceedings Report Classification · 95% confidence The document is a regulatory announcement from a listed company (1795 美時) disclosing a penalty imposed by the Fair Trade Commission for violation of competition law. It details the penalty amount, the company's response, and future actions. There are no financial statements, no report attachments, no meeting materials, or executive changes. The content is about a legal/regulatory matter involving a fine and administrative litigation plans. This fits the category of Legal Proceedings Report (LTR) as it updates on a significant regulatory action against the company.
2021-05-12 Chinese
代重要子公司Alvogen Korea Holdings Ltd.公告完成減資 變更登記
Capital/Financing Update Classification · 95% confidence The document is a short announcement (919 characters) about a capital reduction (減資) completed by a subsidiary, including details on capital amount before and after reduction, share count changes, and net asset value per share impact. It is not a full financial report but a specific update on capital structure changes. The document does not contain comprehensive financial statements or analysis, nor is it a report publication announcement. It fits the category of Capital/Financing Update (CAP) as it informs about changes in capital structure and share count due to capital reduction.
2021-05-10 Chinese
110年4月營業收入
Regulatory Filings Classification · 95% confidence The document is a summarized revenue report for a company named 美時 for the month and cumulative period of 民國110年04月 (April 2021). It contains numerical data on net operating revenue, percentage changes compared to the previous year, and explanations for revenue changes. The document is very short (799 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of monthly revenue figures rather than a full financial report or earnings release. There is no indication of it being an earnings release (ER) since it lacks key highlights or quarterly results, nor is it an annual or interim report. It is a regulatory announcement of financial data, fitting best under Regulatory Filings (RNS).
2021-05-10 Chinese
110年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 美時, providing information on fund loans and endorsement guarantees for the current and previous months. It contains tabulated data on financial guarantees and limits but does not include comprehensive financial statements or detailed analysis. The document length is only 619 characters, indicating it is a short regulatory disclosure rather than a full report. There is no indication that this is an announcement of a report publication or a certification. The content fits best as a general regulatory announcement or compliance disclosure that does not fit into more specific categories like Annual Report or Interim Report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-05-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.